Fab-conjugated PLGA nanoparticles effectively target cancer cells expressing human CD44v6.

Kennedy PJ, Sousa F, Ferreira D, Pereira C, Nestor M, Oliveira C, Granja PL, Sarmento B

Open source

DOI
10.1016/j.actbio.2018.09.043
Published
2018 Nov
Container
Acta biomaterialia
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.actbio.2018.09.043,
  title = {Fab-conjugated PLGA nanoparticles effectively target cancer cells expressing human CD44v6.},
  author = {Kennedy PJ and Sousa F and Ferreira D and Pereira C and Nestor M and Oliveira C and Granja PL and Sarmento B},
  year = {2018},
  journal = {Acta biomaterialia},
  doi = {10.1016/j.actbio.2018.09.043},
  url = {https://doi.org/10.1016/j.actbio.2018.09.043}
}

RIS

TY  - JOUR
TI  - Fab-conjugated PLGA nanoparticles effectively target cancer cells expressing human CD44v6.
AU  - Kennedy PJ
AU  - Sousa F
AU  - Ferreira D
AU  - Pereira C
AU  - Nestor M
AU  - Oliveira C
AU  - Granja PL
AU  - Sarmento B
PY  - 2018
JO  - Acta biomaterialia
DO  - 10.1016/j.actbio.2018.09.043
UR  - https://doi.org/10.1016/j.actbio.2018.09.043
ER  - 

APA

PJ, K., F, S., D, F., C, P., M, N., C, O., PL, G., & B, S. (2018). Fab-conjugated PLGA nanoparticles effectively target cancer cells expressing human CD44v6.. Acta biomaterialia. https://doi.org/10.1016/j.actbio.2018.09.043

Source records